These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27469387)

  • 41. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiovascular adverse effects due to phenylephrine eye drops in ophtalmic surgery].
    Kauffmann S; Commun F; Schoeffler P; Souteyrand G; Chiambaretta F; Dewachter P
    Ann Fr Anesth Reanim; 2013 Feb; 32(2):112-4. PubMed ID: 23375495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of ocular drugs in pediatrics.
    LaRoche GR
    Ophthalmology; 1987 Feb; 94(2):202-3. PubMed ID: 3574888
    [No Abstract]   [Full Text] [Related]  

  • 44. [Eye drops in anesthesia: real drugs, real adverse events].
    Devys JM; Gras S
    Ann Fr Anesth Reanim; 2013 Feb; 32(2):82-3. PubMed ID: 23473442
    [No Abstract]   [Full Text] [Related]  

  • 45. [The influence of phenylephrine and tropicamide on higher order monochromatic aberrations].
    Jurkutat S; Loosberg B; Hemmelmann C; Dawszynski J; Strobel J
    Ophthalmologe; 2007 Mar; 104(3):226-9. PubMed ID: 17294158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort study.
    van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
    BMJ Open; 2015 Dec; 5(12):e008798. PubMed ID: 26700273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contact allergy to atropine and other mydriatic agents in eye drops.
    Decraene T; Goossens A
    Contact Dermatitis; 2001 Nov; 45(5):309-10. PubMed ID: 11722501
    [No Abstract]   [Full Text] [Related]  

  • 48. Epileptic seizures induced by cycloplegic eye drops.
    Wygnanski-Jaffe T; Nucci P; Goldchmit M; Mezer E
    Cutan Ocul Toxicol; 2014 Jun; 33(2):103-8. PubMed ID: 23815170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity.
    Gal P; Kissling GE; Young WO; Dunaway KK; Marsh VA; Jones SM; Shockley DH; Weaver NL; Carlos RQ; Ransom JL
    Ann Pharmacother; 2005 Jun; 39(6):1029-33. PubMed ID: 15855243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angle closure glaucoma in the Northern Ireland Diabetic Retinopathy Screening Programme.
    Lagan MA; O'Gallagher MK; Johnston SE; Hart PM
    Eye (Lond); 2016 Aug; 30(8):1091-3. PubMed ID: 27229706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bilateral spontaneous pigment epithelial detachments in a premature neonate.
    Berman DH; Deutsch JA
    Arch Ophthalmol; 1994 Feb; 112(2):161-2. PubMed ID: 8311763
    [No Abstract]   [Full Text] [Related]  

  • 52. Systemic effects of screening for retinopathy of prematurity.
    Laws DE; Morton C; Weindling M; Clark D
    Br J Ophthalmol; 1996 May; 80(5):425-8. PubMed ID: 8695564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenylephrine is a frequent cause of periorbital allergic contact dermatitis.
    Madsen JT; Andersen KE
    Contact Dermatitis; 2015 Jul; 73(1):64-5. PubMed ID: 25854916
    [No Abstract]   [Full Text] [Related]  

  • 54. Periorbital skin pallor due to skin vasoconstriction following 2.5% phenylephrine mydriatic eye drops instillation prior to retinopathy of prematurity treatment in preterm infant.
    Clariot S; Metge F; Dupont C; Devys JM
    Paediatr Anaesth; 2024 Mar; 34(3):277-278. PubMed ID: 38055349
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of a new preoperative ophthalmic solution.
    Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
    Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular effects of mydriatics in low-birth-weight infants.
    Isenberg S; Everett S
    J Pediatr; 1984 Jul; 105(1):111-2. PubMed ID: 6737125
    [No Abstract]   [Full Text] [Related]  

  • 57. Retinopathy of prematurity screening criteria in Iran: new screening guidelines.
    Roohipoor R; Karkhaneh R; Farahani A; Ebrahimiadib N; Modjtahedi B; Fotouhi A; Yaseri M; Khodabande A; Zarei M; Imani Fuladi M; Taheri A; Riazi Esfahani M; Loewenstein J
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F288-93. PubMed ID: 27073259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of two commonly used mydriatics on choroidal thickness: direct and crossover effects.
    Kara N; Demircan A; Karatas G; Ozgurhan EB; Tatar G; Karakucuk Y; Basci A; Demirok A
    J Ocul Pharmacol Ther; 2014 May; 30(4):366-70. PubMed ID: 24476454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic allergic contact dermatitis due to phenylephrine in eyedrops, with a long-lasting allergic patch test reaction.
    Tamagawa-Mineoka R; Katoh N; Yoneda K; Cho Y; Kishimoto S
    Eur J Dermatol; 2010; 20(1):125-6. PubMed ID: 19822484
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of Topical Anesthesia on Reducing Pain Associated with Mydriatic Eye Drops during Retinopathy of Prematurity Screening.
    Kara C; Petriçli İS; Uzlu SE; Çuni BT
    Ophthalmologica; 2022; 245(5):487-494. PubMed ID: 36108603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.